Venus Concept Receives 510(k) Clearance for Use of its AI.ME™ Next Generation Robotic Technology for Fractional Skin Resurfacing

December 21, 2022

https://www.globenewswire.com/news-release/2022/12/21/2577749/0/en/Venus-Concept-Receives-510-k-Clearance-for-Use-of-its-AI-ME-Next-Generation-Robotic-Technology-for-Fractional-Skin-Resurfacing.html

Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ:VERO), a global medical aesthetic technology leader, today announced that it has received a 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to market its AI.ME next generation robotic technology for fractional skin resurfacing.

Read more at globenewswire.com

Related news for (VERO)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.